SPY749.60−0.63%QQQ674.25−0.83%BTC/USD67,046.40−1.74%DIA521.21−0.37%GLD355.70+0.07%TLT79.42+0.05%

UroGen Pharma Ltd

URGNNASDAQ

Trade with Public

$26.18

-0.21-0.8%

At close: Nov 13, 4:00 PM EST

$26.18

N/A

After Hours: 4:00 PM EST

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

UroGen Pharma (URGN) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for UroGen Pharma (URGN) stock.

Analyst Consensus — 9 Analysts

8Buy

1Hold

# Analysts9

Latest Upgrades and Downgrades for UroGen Pharma Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Guggenheim	Michael Schmidt	PT Cut	Buy	$58→$56
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$75
—	Guggenheim	Michael Schmitz	PT Raise	Buy	$42→$58
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$45→$75
—	TD Cowen	Tara Bancroft	PT Raise	Buy	$50→$60
—	Guggenheim	Brad Canino	PT Raise	Buy	$32→$42
—	Oppenheimer	Leland Gershell	PT Raise	Outperform→Outperformer	$40→$50
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$45
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$45
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$40→$45
—	Oppenheimer	Leland Gershell	PT Raise	Outperform	$34→$40
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$33
—	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$40
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$25
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$25
—	Piper Sandler	Kelsey Goodwin	Initiate	Overweight	$36
—	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$50→$40

UroGen Pharma Ltd

UroGen Pharma (URGN) Stock Price Target 2026

Latest Upgrades and Downgrades for UroGen Pharma Stock

UroGen Pharma (URGN) Stock Price Target 2026

Latest Upgrades and Downgrades for UroGen Pharma Stock

Analyst Ratings News

PRO
Guggenheim Maintains Buy on UroGen Pharma, Lowers Price Target to $56

PRO
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $58

PRO
HC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $75

PRO
TD Cowen Maintains Buy on UroGen Pharma, Raises Price Target to $60

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Guggenheim Maintains Buy on UroGen Pharma, Lowers Price Target to $56

PRO
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $58

PRO
HC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $75

PRO
TD Cowen Maintains Buy on UroGen Pharma, Raises Price Target to $60

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42

UroGen Pharma Ltd

UroGen Pharma (URGN) Stock Price Target 2026

Latest Upgrades and Downgrades for UroGen Pharma Stock

UroGen Pharma (URGN) Stock Price Target 2026

Latest Upgrades and Downgrades for UroGen Pharma Stock

Analyst Ratings News

PROGuggenheim Maintains Buy on UroGen Pharma, Lowers Price Target to $56

PROHC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target

PROGuggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $58

PROHC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $75

PROTD Cowen Maintains Buy on UroGen Pharma, Raises Price Target to $60

PROGuggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42

People Also Watch

People Also Watch

Analyst Ratings News

PROGuggenheim Maintains Buy on UroGen Pharma, Lowers Price Target to $56

PROHC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target

PROGuggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $58

PROHC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $75

PROTD Cowen Maintains Buy on UroGen Pharma, Raises Price Target to $60

PROGuggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42

PRO
Guggenheim Maintains Buy on UroGen Pharma, Lowers Price Target to $56

PRO
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $58

PRO
HC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $75

PRO
TD Cowen Maintains Buy on UroGen Pharma, Raises Price Target to $60

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42

PRO
Guggenheim Maintains Buy on UroGen Pharma, Lowers Price Target to $56

PRO
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $58

PRO
HC Wainwright & Co. Maintains Buy on UroGen Pharma, Raises Price Target to $75

PRO
TD Cowen Maintains Buy on UroGen Pharma, Raises Price Target to $60

PRO
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42